Federal contract award

75H71020F81222

THOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNAVAJO AREA INDIAN HEALTH SVC
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicle36W79720D0001
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$1.0M
Current contract value$1.0M
Potential contract value / ceiling$1.0M
Start dateAug 6, 2020
Current end dateAug 8, 2022
Potential end dateAug 8, 2022
Latest award activityAug 24, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 24, 2026P00009$-426.2KFY26 UDO INITIATIVE
Jun 27, 2022P00008$500.0KTHOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT
Mar 4, 2022P00007$180.0KTHOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT
Jan 13, 2022P00006$130.0KTHOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT
Nov 3, 2021P00005$20.0KTHOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT
Aug 6, 2021P00004$50.0KTHOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT
Jul 2, 2021P00003$175.0KTHOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT
Apr 15, 2021P00002$150.0KTHOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT
Dec 29, 2020P00001$80.0KTHOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT
Aug 7, 20200$150.0KTHOREAU HEALTH CLINIC - FSS ACCOUNT - MCKESSON CORPORATION***PHARMACY DEPARTMENT

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.